JOYCE SAMUEL: Open Payments
NPI 1902057284 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 99 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $257 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $236 |
| Celltrion USA Inc. | 23 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $186 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| Acera Surgical, Inc. | 4 | $92 |
| Janssen Biotech, Inc. | 4 | $72 |
| Phathom Pharmaceuticals, Inc. | 9 | $54 |
| GENZYME CORPORATION | 3 | $53 |
| Lilly USA, LLC | 3 | $52 |
| Medtronic, Inc. | 1 | $47 |
Products named: VEGZELMA, ENTYVIO, XIFAXAN, SKYRIZI, Restrata Wound Matrix, RINVOQ, TREMFYA, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
